Table 1.
ID of CpG unit 1 | Gene symbol | Chromo- some |
Position of CpG site 2 | AUC value | Cutoff value 3(%) | Sensitivity
4
(%) |
Specificity
4
(%) |
---|---|---|---|---|---|---|---|
81 | TRH | 3 | 129693406, 129693412 | 0.973 | 30.8 | 100.0 | 88.6 |
85 | TRH | 3 | 129693518, 129693521, 129693528 | 0.950 | 18.2 | 100.0 | 78.4 |
89 | TRH | 3 | 129693586 | 0.952 | 11.0 | 92.3 | 92.0 |
94 | TRH | 3 | 129693635 | 0.967 | 6.6 | 100.0 | 87.5 |
8 | FAM150A | 8 | 53478477 | 0.968 | 27.2 | 83.3 | 94.1 |
11 | FAM150A | 8 | 53478511 | 0.968 | 27.2 | 83.3 | 94.1 |
78 | PRAC | 17 | 46799755 | 0.957 | 40.7 | 92.9 | 89.8 |
102 | SLC13A5 | 17 | 6616733 | 0.983 | 7.5 | 92.9 | 96.6 |
105 | SLC13A5 | 17 | 6616812 | 0.983 | 18.5 | 100.0 | 94.3 |
106 | SLC13A5 | 17 | 6616826, 6616828 | 0.951 | 23.3 | 100.0 | 88.6 |
107 | SLC13A5 | 17 | 6616851, 6616854, 6616857 | 0.954 | 14.8 | 100.0 | 87.5 |
110 | SLC13A5 | 17 | 6616927, 6616929 | 0.951 | 23.3 | 100.0 | 88.6 |
30 | ZNF540 | 19 | 38042496 | 0.983 | 41.0 | 100.0 | 98.3 |
32 | ZNF540 | 19 | 38042518 | 0.960 | 35.7 | 100.0 | 93.1 |
33 | ZNF540 | 19 | 38042530, 38042532 | 0.991 | 36.4 | 100.0 | 96.6 |
43 | ZNF154 | 19 | 58220567 | 0.956 | 13.3 | 92.9 | 90.9 |
44 | ZNF154 | 19 | 58220627 | 0.966 | 14.8 | 85.7 | 95.5 |
45 | ZNF154 | 19 | 58220657, 58220662 | 0.959 | 22.2 | 92.9 | 95.5 |
149 | ZNF671 | 19 | 58238780 | 0.954 | 15.2 | 85.7 | 89.7 |
158 | ZNF671 | 19 | 58238928 | 0.965 | 10.5 | 100.0 | 88.5 |
160 | ZNF671 | 19 | 58238954 | 0.954 | 15.2 | 85.7 | 89.7 |
161 | ZNF671 | 19 | 58238987 | 0.954 | 15.2 | 85.7 | 89.7 |
163 | ZNF671 | 19 | 58239012 | 0.951 | 10.5 | 85.7 | 92.0 |
1ID of CpG unit is defined in Additional file 4: Table S4.
2National Center for Biotechnology Information (NCBI) Database (Genome Build 37).
3The Youden index was used as a cutoff value for discriminating CIMP-positive ccRCCs in the learning cohort from CIMP-negative ccRCCs. When the cancerous tissue shows a DNA methylation level equal to or higher than the cutoff value, the ccRCC is considered to be CIMP-positive; when the cancerous tissue shows a DNA methylation level lower than the cutoff value, the ccRCC is considered to be CIMP-negative.
4Sensitivity and specificity for discrimination of CIMP-positive ccRCCs in the learning cohort from CIMP-negative ccRCCs using individual CpG units.